The Europe diagnostic tests market encompasses a diverse range of medical tests and diagnostic tools utilized to assess and monitor various health conditions. These tests are critical in disease detection, prognosis, and treatment monitoring. The market features various diagnostic methods, including imaging, blood tests, urine tests, and molecular diagnostics. Medical laboratories, hospitals, and clinics are key end-users. Diagnostic tests in Europe are subject to rigorous regulations to ensure accuracy and safety, contributing to the region's high standard of healthcare.
Access full Report @ https://www.databridgemarketresearch.com/jp/reports/europe-diagnostic-tests-market
Data Bridge Market Research analyses that the Europe Diagnostic Tests Market is expected to grow at a CAGR of 9.2% in the forecast period of 2023 to 2030 and is expected to reach USD 3,24,678.67 million by 2030 from USD 1,60,573.05 million in 2022. Disease awareness initiatives, often led by healthcare organizations and advocacy groups, educate the public about specific health conditions, symptoms, and risks. These efforts empower individuals to recognize potential health issues, leading to early testing and diagnosis, ultimately improving treatment outcomes and reducing the burden of diseases.
Key Findings of the Study
Rising chronic diseases are expected to drive the market's growth rate
The escalating prevalence of chronic diseases in Europe has created a pressing need for early detection through diagnostic tests. Conditions such as diabetes, cardiovascular disease, and cancer have become alarmingly common, necessitating timely identification to facilitate effective management. Diagnostic tests play a pivotal role in this process, enabling healthcare providers to initiate interventions earlier, significantly improving patient outcomes, reducing treatment costs, and enhancing overall public health.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Glucose Test, Infectious Diseases Test, Cytology Test, CBC Test, Blood Culture Test, Syphilis Test, Urea Test, C-Reactive Protein Test, Antigen Test, HBA1C Test, Pregnancy Test, Lipid Profile Test, Electrolytes Test, Liver Function Test, Stool Helicobacter Pylori Test, Calcium Test, Crossmatch Test, Thyroid Function Test, Stool Microscopy Test, Urine Microscopy Test, Unit Packed RBCS Test, ESR Test and Others Test), Solutions (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gene Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Substrate Technology and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Approach (Molecular Diagnostic Instrument, In-Vitro Diagnostic Instrument and Point Of Care Testing Instrument), Sample Type (Urine, Saliva, Blood, Hair, Sweat and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Odontology and Others), Testing Type (Biochemistry, Haematology, Microbiology, Histopathology and Others), Age (Pediatric, Adult and Geriatric), End User (Hospitals, Diagnostic Center, Research Labs and Institutes, Research Institute, Homecare, Blood Banks, Specialty Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders, Retail Sales and Online Sales)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
|
|
Market Players Covered
|
F-Hoffman La-Roche Ltd. (Switzerland), ABBOTT (U.S.), Danaher (U.S.), B.D. (U.S.), Thermo Fisher Scientific Inc. (U.S.), ACON Laboratories Inc. (U.S.), Hemosure, Inc. (U.S.), MicroGen Diagnostics (U.S.), QIAGEN (Germany), Grifols, S.A (Spain), BODITECH MED INC. (South Korea), Chembio Diagnostic Systems, Inc. (U.S.), Nanoentek (South Korea), DiaSorin S.p.A. (Italy), Bio-Rad Laboratories, Inc. (U.S.), BIOMEDOMICS INC (U.S.), EKF Diagnostics Holdings plc (U.K.), Siemens Healthcare GmbH (Germany), PerkinElmer Inc. (U.S.), BIOMÉRIEUX (France), ARKRAY USA, Inc. (U.S.), Biohit Oyj (Finland), Germaine Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), Illumina, Inc. (U.S.), Lamdagen Corporation (U.S.), LifeSign LLC. (U.S.), Medixbiochemica (Finland), Nova Biomedical (U.S.), Ortho Clinical Diagnostics (U.S.), Sannuo Biosensing Co., Ltd. (U.S.), STRECK (U.S.), Sysmex Corporation (Japan), among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Europe diagnostic tests market is segmented on the basis of type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel.
- On the basis of type, the Europe diagnostic tests market is segmented into glucose test, infectious diseases test, cytology test, CBC test, blood culture test, syphilis test, urea test, C-reactive protein test, antigen test, HBA1C test, pregnancy test, lipid profile test, electrolytes test, liver function test, stool helicobacter pylori test, calcium test, crossmatch test, thyroid function test, stool microscopy test, urine microscopy test, unit packed RBCS test, ESR test and others test
- On the basis of solution, the Europe diagnostic tests market is segmented into services and products
- On the basis of technology, the Europe diagnostic tests market is segmented into immunoassay-based, PCR-based, next gene sequencing, spectroscopy-based, chromatography-based, microfluidics, substrate technology and others
- On the basis of mode of testing, the Europe diagnostic tests market is segmented into prescription-based testing and OTC testing
- On the basis of approach, the Europe diagnostic tests market is segmented into molecular diagnostic instrument, in-vitro diagnostic instrument and point of care testing instrument
- On the basis of sample type, the Europe diagnostic tests market is segmented into urine, saliva, blood, hair, sweat, and others
- On the basis of application, the Europe diagnostic tests market is segmented into cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, odontology, and others
- On the basis of testing type, the Europe diagnostic tests market is segmented into biochemistry, haematology, microbiology, histopathology, and others
- On the basis of age, the Europe diagnostic tests market is segmented into pediatric, adult and geriatric
- On the basis of end user, the Europe diagnostic tests market is segmented into hospitals, diagnostic center, research labs and institutes, research institute, homecare, blood banks, specialty clinics, ambulatory surgical centers, and others
- On the basis of distribution channel, the Europe diagnostic tests market is segmented into direct tenders, retail sales, and online sales
Major Players
Data Bridge Market Research recognizes the following companies as the major Europe diagnostic tests market players in Europe diagnostic tests market are F-Hoffman La-Roche Ltd. (Switzerland), ABBOTT (U.S.), Danaher (U.S.), B.D. (U.S.), Thermo Fisher Scientific Inc. (U.S.), ACON Laboratories Inc. (U.S.), Hemosure, Inc. (U.S.), MicroGen Diagnostics (U.S.), QIAGEN (Germany), Grifols, S.A (Spain).
Market Developments
- In June 2023, Siemens Healthineers, a leading medical technology company, revealed a strategic collaboration with Roche Diagnostics in the Europe diagnostic tests market. This alliance aims to enhance diagnostic capabilities, fostering innovative solutions. Siemens Healthineers' cutting-edge imaging technology and Roche Diagnostics' advanced testing expertise promise groundbreaking developments in healthcare diagnostics.
- In May 2020, F. Hoffmann-La Roche Ltd revealed its acquisition of Stratos Genomics in Europe, strengthening its foothold in the Diagnostic Tests Market. This strategic move bolstered Roche's healthcare diagnosis capabilities through DNA-based sequencing, driving increased revenue for the company.
- In April 2020, Leica Microsystems, a subsidiary of Danaher, announced their groundbreaking STELLARIS platform in Europe, revolutionizing diagnostic tests. This innovative confocal microscopy system enables three-dimensional visualization of tissues and living cells, marking a significant development in the Europe diagnostic tests market.
Regional Analysis
Geographically, the countries covered in the Europe diagnostic tests market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
As per Data Bridge Market Research analysis:
Germany is the dominant region in Europe diagnostic tests market during the forecast period 2023 -2030
Germany leads the European diagnostic tests market through government-backed strategies such as acquisitions and targeted product launches. These initiatives aid in market expansion and diversification of product offerings, driving increased revenue within the country.
For more detailed information about the Europe diagnostic tests market report, click here – https://www.databridgemarketresearch.com/jp/reports/europe-diagnostic-tests-market
